- Rite Aid takes a bite out of obesity; relaunches weight-loss program for New Year
- Gallup: Take Care Clinics top in customer service
- The Little Clinic adds new insurance provider to accepted plans
- Diabetes population to double, costs to nearly triple by 2034
- FDA approves Bayer Diabetes Care's Contour USB blood glucose meter
CLIFFSIDE PARK, N.J. The U.S. Patent and Trademark Office has granted a patent to the privately owned company Pop Test for a means for diabetics to measure their glucose levels without drawing blood, Pop Test said Tuesday.
The company said it is conducting clinical trials on a glucose test that uses saliva to allow Type 1 and Type 2 diabetes patients to monitor blood glucose, and can detect abnormally low and abnormally high blood sugar levels.
The company also is developing tests for cholesterol, stress, drugs and alcohol, and pregnancy.
“The Pop Test device will be a tremendous benefit to the millions of people who are afflicted with diabetes around the world,” Pop Test founder Randi Altschul said. “Consumers will be able to monitor their health condition at home with a simple, affordable and painless self-testing device that uses saliva reliably instead of blood.”